Anteris Technologies (ASX: AVR) Surges 30% on Medtronic Deal- Is It a Buy?

Anteris Technologies Gains Momentum with Medtronic Partnership Anteris Technologies (ASX: AVR) jumped more than 30% after announcing a deal that could change its future. The Australian heart valve company secured…

ByUjjwal Maheshwari

19

Jan 2026

Healthcare Stocks

Osteopore (ASX:OSX) Secures A$2.6M China Deal: Micro-Cap Opportunity or Too Risky to Buy?

Osteopore signs a major China distribution deal, but risks remain Osteopore (ASX: OSX) surged 71 per cent last Friday after announcing an exclusive distribution deal with Majeton Limited valued at…

ByUjjwal Maheshwari

19

Jan 2026

Healthcare Stocks

Proteomics International (ASX:PIQ) Appoints New CEO as US Sales Push Begins: Is It Time to Buy?

Proteomics International begins its US sales push as Medicare reimbursement starts At Proteomics International (ASX: PIQ), new CEO David Morris takes the reins today as the Perth-based medical technology company shifts…

ByUjjwal Maheshwari

14

Jan 2026

Healthcare Stocks

Singular Health (ASX:SHG) Gains FDA Clearance for Cloud Imaging Platform: Is This MedTech a Buy Now?

Singular Health secures FDA clearance for US rollout Singular Health Group (ASX: SHG) grabbed investor attention on Tuesday after the company announced FDA 510(k) clearance for its 3DICOM MD Cloud…

ByUjjwal Maheshwari

13

Jan 2026

Healthcare Stocks

EBR Systems (ASX:EBR) Surges 7.6% on Q4 Momentum: Time to Buy Before Full US Launch?

EBR Systems Gains Momentum Ahead of 2026 US Launch EBR Systems (ASX: EBR) is building serious momentum as it moves closer to a full US commercial launch in 2026. Shares…

ByUjjwal Maheshwari

09

Jan 2026

Healthcare Stocks

Ansell (ASX:ANN) Drops 6% on CEO Exit: Is This a Buying Opportunity?

Is Ansell's CEO Change a Hidden Opportunity for Investors? Ansell (ASX: ANN) fell over 6% on Thursday after announcing that CEO Neil Salmon will retire, with the stock dropping to…

ByUjjwal Maheshwari

29

Dec 2025

Healthcare Stocks

Monash IVF (ASX:MVF) Plunges 15% as $312m Takeover Bid Collapses- Is This a Buying Opportunity?

Monash IVF: Is This a Buying Opportunity? Monash IVF (ASX: MVF) shares crashed 15% to 69.5 cents last week after Soul Patts and Genesis Capital abruptly withdrew their A$312 million…

ByUjjwal Maheshwari

23

Dec 2025

Healthcare Stocks

Is Pro Medicus (ASX:PME) a Buy After the 34% Pullback?

Pro Medicus slips, growth momentum remains Pro Medicus (ASX: PME) has dropped approximately 34% from its record high of A$336 in July 2025 and now trades near A$222. Investors are…

ByUjjwal Maheshwari

23

Dec 2025

Healthcare Stocks

Regis Healthcare (ASX:REG) Drops Below $7.20 on CEO Exit: A Buying Opportunity?

Regis Healthcare CEO Exit: What Investors Watch Next Regis Healthcare (ASX: REG) shares fell 2.6% to A$7.13 after CEO Dr Linda Mellors announced her resignation to pursue a career opportunity…

ByUjjwal Maheshwari

16

Dec 2025

Biotech Stocks

Cynata Therapeutics Completes Phase 2 Enrollment- Buy Before June or Wait for the Data?

Cynata Therapeutics (ASX: CYP) has completed patient enrollment in its Phase 2 clinical trial of a stem cell treatment called CYP-001 for acute graft versus host disease (aGvHD), a potentially…

ByUjjwal Maheshwari

Anteris Technologies (ASX: AVR) Surges 30% on Medtronic Deal- Is It a Buy?

Osteopore (ASX:OSX) Secures A$2.6M China Deal: Micro-Cap Opportunity or Too Risky to Buy?

Proteomics International (ASX:PIQ) Appoints New CEO as US Sales Push Begins: Is It Time to Buy?

Singular Health (ASX:SHG) Gains FDA Clearance for Cloud Imaging Platform: Is This MedTech a Buy Now?

EBR Systems (ASX:EBR) Surges 7.6% on Q4 Momentum: Time to Buy Before Full US Launch?

Ansell (ASX:ANN) Drops 6% on CEO Exit: Is This a Buying Opportunity?

Monash IVF (ASX:MVF) Plunges 15% as $312m Takeover Bid Collapses- Is This a Buying Opportunity?

Is Pro Medicus (ASX:PME) a Buy After the 34% Pullback?

Regis Healthcare (ASX:REG) Drops Below $7.20 on CEO Exit: A Buying Opportunity?

Cynata Therapeutics Completes Phase 2 Enrollment- Buy Before June or Wait for the Data?

PLS Group (ASX:PLS) Hits Record High on...

Narryer Metals (ASX:NYM) Tim Goyder Back...

Sovereign Metals (ASX:SVM) DFS lands,$2....

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here